Thy1 (cd90) maintains the adherens junctions in nasopharyngeal carcinoma via inhibition of src activation

HIGHLIGHTS

  • who: Luo Chen and collaborators from the Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Hong Kong, China have published the article: THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation, in the Journal: Cancers 2023, 2189 of /2023/
  • what: The authors show that tumor invasion could be suppressed by adherens junction formation in a few cell lines and knockdown of would disrupt this cell-cell adhesion phenotype. In this study, such mechanism was investigated and whether the THY1 downstream signaling pathway could be used as a drug_target . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?